Davila Diego, Antoniou Alexander, Chaudhry Muhammad A
Russel H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD.
Russel H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD
Semin Nucl Med. 2015 Jan;45(1):3-15. doi: 10.1053/j.semnuclmed.2014.07.004.
Bone scintigraphy (BS) is an imaging tool commonly used for screening patients with cancer, especially those with high prevalence of osseous metastases including the breast, prostate, lung, thyroid, and kidney, which account for 80% of osseous metastasis. BS has been shown to be of value in the initial and subsequent treatment strategy of various malignancies. The purpose of this article is to evaluate the technical and imaging aspects of BS and to examine the present research into improved detection of osseous metastasis.
骨闪烁显像(BS)是一种常用于筛查癌症患者的成像工具,尤其是对骨转移发生率较高的患者,包括乳腺癌、前列腺癌、肺癌、甲状腺癌和肾癌患者,这些癌症占骨转移的80%。骨闪烁显像已被证明在各种恶性肿瘤的初始和后续治疗策略中具有价值。本文的目的是评估骨闪烁显像的技术和成像方面,并审视目前关于改进骨转移检测的研究。